Hans Prenen hoogleraar

Publicaties Hans Prenen

Highlights in gastro-intestinal cancer

Bron
Belgian journal of medical oncology - ISSN 1784-7141-12 (2018) p. 182-188
Auteur(s)

Erdafitinib in patients with FGFR-altered advanced or metastatic cholangiocarcinoma

Bron
Clinical cancer research - ISSN 1078-0432-32:6 (2026) p. 1136-1144
Auteur(s)
    Shubham Pant, Joon Oh Park, Wu-Chou Su, Yohann Loriot, Omar Carranza, Marcelo Corassa, Toshihiko Doi, Shukui Qin, Josep Tabernero, Hans Prenen, Gunnar Folprecht, Helen Winter, Graziela Z. Dal Molin, Lin Shen, Jiaqi Qian, Huimin Liao, Shibu Thomas, Hussein Sweiti, Spyros Triantos, Yin-Hsun Feng

Beamion PANTUMOR-1 : rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors

Bron
Future oncology - ISSN 1479-6694-22:7 (2026) p. 795-803
Auteur(s)
    Alison M. Schram, John J. Park, Antoine Italiano, Shigehisa Kitano, Ye Guo, Jin Li, Philippe L. Bedard, Cedric van Marcke, Ryo Ko, Lukas Lunger, Daniel M. Klotz, Jo Hussain, Daniela Maier, Damijan Erzen, David Planchard, Hans Prenen, Timothy D. Clay, Joon O. Park, Hyung-Don Kim, Alberto Hernando-Calvo, Yuta Maruki, Mariano Ponz-Sarvise, Ecaterina Dumbrava

DRP1 depletion protects NK cells from hypoxia-induced dysfunction

Bron
Redox report: communications in free radical research - ISSN 1351-0002-31:1 (2026) p. 1-20
Auteur(s)